Jon E. Angell

Array ( [id] => 4866287 [patent_doc_number] => 20080145346 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-06-19 [patent_title] => 'Methods And Compounds For Altering The Load Of Hepatitis Virus' [patent_app_type] => utility [patent_app_number] => 10/583068 [patent_app_country] => US [patent_app_date] => 2004-11-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 25 [patent_figures_cnt] => 25 [patent_no_of_words] => 15480 [patent_no_of_claims] => 52 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0145/20080145346.pdf [firstpage_image] =>[orig_patent_app_number] => 10583068 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6977950 [patent_doc_number] => 20050287668 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-12-29 [patent_title] => 'RNA interference compositions and screening methods for the identification of novel genes and biological pathways' [patent_app_type] => utility [patent_app_number] => 10/976467 [patent_app_country] => US [patent_app_date] => 2004-10-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 20433 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0287/20050287668.pdf [firstpage_image] =>[orig_patent_app_number] => 10976467 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6938624 [patent_doc_number] => 20050112187 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-05-26 [patent_title] => 'Combination product intended for carrying out a cytotoxic treatment, in particular an antitumour treatment, in a mammal' [patent_app_type] => utility [patent_app_number] => 10/978119 [patent_app_country] => US [patent_app_date] => 2004-10-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 12747 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0112/20050112187.pdf [firstpage_image] =>[orig_patent_app_number] => 10978119 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4634493 [patent_doc_number] => 08012944 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-09-06 [patent_title] => 'Method for treating cancer using IAP antisense oligomer and chemotherapeutic agent' [patent_app_type] => utility [patent_app_number] => 10/975790 [patent_app_country] => US [patent_app_date] => 2004-10-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 34 [patent_figures_cnt] => 47 [patent_no_of_words] => 23757 [patent_no_of_claims] => 35 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 51 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/012/08012944.pdf [firstpage_image] =>[orig_patent_app_number] => 10975790 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5182927 [patent_doc_number] => 20070054274 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-03-08 [patent_title] => 'Gene modulation by rb2/p130 expression' [patent_app_type] => utility [patent_app_number] => 10/574407 [patent_app_country] => US [patent_app_date] => 2004-09-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 5449 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0054/20070054274.pdf [firstpage_image] =>[orig_patent_app_number] => 10574407 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 14100 [patent_doc_number] => 07803906 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-09-28 [patent_title] => 'Composition comprising an angiogenesis related protein' [patent_app_type] => utility [patent_app_number] => 10/947476 [patent_app_country] => US [patent_app_date] => 2004-09-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 5 [patent_no_of_words] => 12316 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 89 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/803/07803906.pdf [firstpage_image] =>[orig_patent_app_number] => 10947476 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7083838 [patent_doc_number] => 20050049218 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-03-03 [patent_title] => 'Method for treating fibrosis' [patent_app_type] => utility [patent_app_number] => 10/938375 [patent_app_country] => US [patent_app_date] => 2004-09-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 17830 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0049/20050049218.pdf [firstpage_image] =>[orig_patent_app_number] => 10938375 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6997359 [patent_doc_number] => 20050137137 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-06-23 [patent_title] => 'Inhibitors of the Interaction between p53 and MDM2' [patent_app_type] => utility [patent_app_number] => 10/927262 [patent_app_country] => US [patent_app_date] => 2004-08-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 16896 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0137/20050137137.pdf [firstpage_image] =>[orig_patent_app_number] => 10927262 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6912267 [patent_doc_number] => 20050176025 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-08-11 [patent_title] => 'RNA interference mediated inhibition of B-cell CLL/Lymphoma-2 (BCL-2) gene expression using short interfering nucleic acid (siNA)' [patent_app_type] => utility [patent_app_number] => 10/923516 [patent_app_country] => US [patent_app_date] => 2004-08-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 25 [patent_figures_cnt] => 25 [patent_no_of_words] => 66180 [patent_no_of_claims] => 35 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0176/20050176025.pdf [firstpage_image] =>[orig_patent_app_number] => 10923516 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5101780 [patent_doc_number] => 20070185042 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-08-09 [patent_title] => 'Sirna based methods for treating alzheimer\'s disease' [patent_app_type] => utility [patent_app_number] => 10/567537 [patent_app_country] => US [patent_app_date] => 2004-08-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 11872 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0185/20070185042.pdf [firstpage_image] =>[orig_patent_app_number] => 10567537 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4759330 [patent_doc_number] => 20080311556 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-12-18 [patent_title] => 'Sense Antiviral Compound and Method for Treating Ssrna Viral Infection' [patent_app_type] => utility [patent_app_number] => 10/567470 [patent_app_country] => US [patent_app_date] => 2004-08-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 14106 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0311/20080311556.pdf [firstpage_image] =>[orig_patent_app_number] => 10567470 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7020045 [patent_doc_number] => 20050222064 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-10-06 [patent_title] => 'Polycationic compositions for cellular delivery of polynucleotides' [patent_app_type] => utility [patent_app_number] => 10/888269 [patent_app_country] => US [patent_app_date] => 2004-07-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 33036 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 19 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0222/20050222064.pdf [firstpage_image] =>[orig_patent_app_number] => 10888269 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 12687 [patent_doc_number] => 07807148 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-10-05 [patent_title] => 'Organotypically cultured skin tissue comprising NIKS cells that express exogenous HIF-1a' [patent_app_type] => utility [patent_app_number] => 10/848646 [patent_app_country] => US [patent_app_date] => 2004-05-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 21181 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 67 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/807/07807148.pdf [firstpage_image] =>[orig_patent_app_number] => 10848646 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6997375 [patent_doc_number] => 20050137153 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-06-23 [patent_title] => 'RNA interference mediated inhibition of alpha-1 antitrypsin (AAT) gene expression using short interfering nucleic acid (siNA)' [patent_app_type] => utility [patent_app_number] => 10/840731 [patent_app_country] => US [patent_app_date] => 2004-05-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 24 [patent_figures_cnt] => 24 [patent_no_of_words] => 58704 [patent_no_of_claims] => 35 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0137/20050137153.pdf [firstpage_image] =>[orig_patent_app_number] => 10840731 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7346548 [patent_doc_number] => 20040192598 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-09-30 [patent_title] => 'Composition and method of alleviating adverse side effects and/or enhancing efficacy of agents that inhibit aromatase' [patent_app_type] => new [patent_app_number] => 10/474838 [patent_app_country] => US [patent_app_date] => 2004-05-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9531 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 35 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0192/20040192598.pdf [firstpage_image] =>[orig_patent_app_number] => 10474838 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6992665 [patent_doc_number] => 20050091702 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-04-28 [patent_title] => 'Expression of polypeptides in rod outer segment membranes' [patent_app_type] => utility [patent_app_number] => 10/831773 [patent_app_country] => US [patent_app_date] => 2004-04-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 16 [patent_no_of_words] => 18331 [patent_no_of_claims] => 33 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0091/20050091702.pdf [firstpage_image] =>[orig_patent_app_number] => 10831773 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7267238 [patent_doc_number] => 20040244070 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-12-02 [patent_title] => 'Expression of polypeptides in rod outer segment membranes' [patent_app_type] => new [patent_app_number] => 10/830908 [patent_app_country] => US [patent_app_date] => 2004-04-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 9937 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 31 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0244/20040244070.pdf [firstpage_image] =>[orig_patent_app_number] => 10830908 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5028913 [patent_doc_number] => 20070270360 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-11-22 [patent_title] => 'Rna Interference Mediated Inhibition of Severe Acute Respiratory Syndrome (Sars) Gene Expression Using Short Interfering Nucleic Acid' [patent_app_type] => utility [patent_app_number] => 10/553729 [patent_app_country] => US [patent_app_date] => 2004-04-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 25 [patent_figures_cnt] => 25 [patent_no_of_words] => 72267 [patent_no_of_claims] => 31 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0270/20070270360.pdf [firstpage_image] =>[orig_patent_app_number] => 10553729 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7150965 [patent_doc_number] => 20040171575 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-09-02 [patent_title] => 'Antisense modulation of interferon gamma receptor 2 expression' [patent_app_type] => new [patent_app_number] => 10/819244 [patent_app_country] => US [patent_app_date] => 2004-04-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 25507 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 68 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0171/20040171575.pdf [firstpage_image] =>[orig_patent_app_number] => 10819244 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7264988 [patent_doc_number] => 20040242524 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-12-02 [patent_title] => 'Chemotherapeutic composition and method' [patent_app_type] => new [patent_app_number] => 10/806621 [patent_app_country] => US [patent_app_date] => 2004-03-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 7629 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 3 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0242/20040242524.pdf [firstpage_image] =>[orig_patent_app_number] => 10806621 [rel_patent_id] =>[rel_patent_doc_number] =>)